- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin Glargine 300 UNT/ML
Total 1050 results
-
Emory UniversitySanofiCompletedDiabetic KetoacidosisUnited States
-
SanofiCompleted
-
Baylor College of MedicineCompletedType 1 DiabetesUnited States
-
SanofiCompleted
-
HaEmek Medical Center, IsraelCompletedDiabetes Mellitus Type 2
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Germany, Israel, Czechia, Spain, Russian Federation, Romania, Puerto Rico, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Italy, Canada, Germany, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Germany, United Kingdom, Austria, Belgium, France, Ireland
-
SanofiCompleted
-
Emory UniversitySanofi; University of MiamiCompletedHyperglycemia | DiabetesUnited States
-
University of PalermoCompleted
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
University of GiessenSanofiCompleted
-
Novo Nordisk A/SCompleted
-
SanofiTerminatedDiabetes Mellitus, Type 2Brazil
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
SanofiCompletedDiabetes Mellitus, Type 1Bahrain, Kuwait, Qatar, United Arab Emirates
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
University of Campania "Luigi Vanvitelli"CompletedHypoglycemia | Type 2 Diabetes MellitusItaly
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Mexico, Russian Federation, Netherlands, Belgium, Italy, India, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, France, United Kingdom, Russian Federation, Germany, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1United States
-
RISE Study GroupNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Emory UniversitySanofiCompletedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
SanofiCompletedDiabetes Mellitus, Type 2Turkey
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompleted
-
Novo Nordisk A/SCompleted
-
Mannkind CorporationTerminatedDiabetes, Type 1United States, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Delivery SystemsDenmark
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); SanofiWithdrawnHyperglycemia | LeukemiaUnited States